BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29441886)

  • 1. Effects and mechanisms of ambroxol inhalation (Mucosolvan
    Yang Z; Xiao X; Huang Y; He X; Lu Q; Chen S; Lin Z
    Pharmazie; 2017 Oct; 72(10):604-607. PubMed ID: 29441886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ambroxol inhalation ameliorates LPS-induced airway inflammation and mucus secretion through the extracellular signal-regulated kinase 1/2 signaling pathway.
    Zhang SJ; Jiang JX; Ren QQ; Jia YL; Shen J; Shen HJ; Lin XX; Lu H; Xie QM
    Eur J Pharmacol; 2016 Mar; 775():138-48. PubMed ID: 26872986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic efficacy of high-dose ambroxol and the nursing effects in the treatment of severe pneumonia.
    Wang D; Sun S; Hu S
    Pak J Pharm Sci; 2019 May; 32(3 Special):1409-1413. PubMed ID: 31551222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of mucolytic preparations (Mucosolvan) in selected diseases of the upper respiratory tract. Part II].
    Szmeja Z; Golusiński W; Mielcarek-Kuchta D; Laczkowska-Przybylska J
    Otolaryngol Pol; 1997; 51(5):480-6. PubMed ID: 9557050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhalation and peroral mucolytic therapy in mucoviscidosis in children].
    Uglitskikh AK; Khan MA; Sharapov SV; Kapranov NI; Plisko LF
    Vopr Kurortol Fizioter Lech Fiz Kult; 1996; (5):15-8. PubMed ID: 9036657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxygen-driving and atomized mucosolvan inhalation combined with holistic nursing in the treatment of children severe bronchial pneumonia.
    Yang F
    Pak J Pharm Sci; 2015 Jul; 28(4 Suppl):1477-80. PubMed ID: 26431648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosolvan serves to optimize perioperative airway management for NSCLC patients in fast track surgery: a randomized placebo controlled study.
    Wang JY; Hong X; Chen GH; Li QC; Liu ZM
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(15):2875-81. PubMed ID: 26241543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antenatal ambroxol administration for prevention of respiratopry distress syndrome in preterm infants: preliminary report].
    Marinov B; Jekova N; Andreeva A; Hitrova S
    Akush Ginekol (Sofiia); 2011; 50(4):17-22. PubMed ID: 22479892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of early ambroxol treatment on lung functions in mechanically ventilated preterm newborns who subsequently developed a bronchopulmonary dysplasia (BPD).
    Schmalisch G; Wauer RR; Böhme B
    Respir Med; 2000 Apr; 94(4):378-84. PubMed ID: 10845438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of mucolytic therapy on the production of reactive oxygen species in the blood of patients with an exacerbation of chronic obstructive pulmonary disease].
    Farkhutdinov UR; Farkhutdinov RR; Petriakov VV; Farkhutdinov ShU; Mirkhaĭdarov AM
    Ter Arkh; 2010; 82(3):29-32. PubMed ID: 20564918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ambroxol].
    Akkoca Yildiz O
    Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of inhaled ambroxol treatment on clinical symptoms and chosen parameters of ventilation in patients with exacerbation of chronic obstructive pulmonary disease patients].
    Jahnz-Rózyk K; Kucharczyk A; Chciałowski A; Płusa T
    Pol Merkur Lekarski; 2001 Sep; 11(63):239-43. PubMed ID: 11761819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antenatal use of ambroxol for the prevention of infant respiratory distress syndrome.
    Laoag-Fernandez JB; Fernandez AM; Maruo T
    J Obstet Gynaecol Res; 2000 Aug; 26(4):307-12. PubMed ID: 11049243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhalation of ambroxol inhibits cigarette smoke-induced acute lung injury in a mouse model by inhibiting the Erk pathway.
    Ge LT; Liu YN; Lin XX; Shen HJ; Jia YL; Dong XW; Sun Y; Xie QM
    Int Immunopharmacol; 2016 Apr; 33():90-8. PubMed ID: 26881857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antioxidative features of ambroxol--usefulness in COPD].
    Nowak D
    Pneumonol Alergol Pol; 2001; 69(9-10):590-3. PubMed ID: 11928667
    [No Abstract]   [Full Text] [Related]  

  • 16. Meta-analysis of high doses of ambroxol treatment for acute lung injury/acute respiratory distress syndrome based on randomized controlled trials.
    Wu X; Li S; Zhang J; Zhang Y; Han L; Deng Q; Wan X
    J Clin Pharmacol; 2014 Nov; 54(11):1199-206. PubMed ID: 25174313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in pulmonary function in preterm infants recovering from RDS following early treatment with ambroxol: results of a randomized trial.
    Schmalisch G; Wauer RR; Böhme B
    Pediatr Pulmonol; 1999 Feb; 27(2):104-12. PubMed ID: 10088933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucolytics and antioxidant activity.
    Strapková A; Nosál'ová G; Franová S
    Life Sci; 1999; 65(18-19):1923-5. PubMed ID: 10576438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose ambroxol reduces pulmonary complications in patients with acute cervical spinal cord injury after surgery.
    Li Q; Yao G; Zhu X
    Neurocrit Care; 2012 Apr; 16(2):267-72. PubMed ID: 22006379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of ambroxol given prenatally and postnatally on gas exchange in the newborn with respiratory distress syndrome].
    Sackey S; Gadzinowski J; Szymankiewicz M; Breborowicz GH; Rudnicki J; Patalan J; Rózewicki K
    Ginekol Pol; 1995 Jul; 66(7):409-12. PubMed ID: 8655006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.